INTRODUCTION
Transgenic technology allows the insertion of defi ned genetic material into the germline of mice and other organisms. Of all disciplines of the life sciences few stand to profi t more from this than developmental biology. Important insights into the molecular genetics of development can be gained either by overproducing factors that regulate or interfere with development in specifi c target organs of the growing organism, or by mutating resident chromosomal genes that regulate development. While virtually every new phenotype observed in a transgenic mouse also involves changes in some aspect of development, we will deal selectively with broad changes in pattern formation and in organogenesis initiated by genes that have been inserted or changed in the mouse genome. This field of research is very much at its beginning, hence our review will be short. Nonetheless, we hope to elicit in our readers an interest in the enormous potential of these experiments for the understanding of the molecular genetics of mammalian development.
EXPERIMENTAL DESIGNS
A transgenic mouse is characterized by the presence of foreign DNA sequences inserted in the genome by laboratory techniques. A recent review details this approach (Jaenisch 1988) . Most commonly, a transcription cassette is constructed and injected into a pronucleus of a one-cell embryo so that it can integrate in the host chromatin and become part of every cell of the growing organism. This includes the germ line, so that the original transgenic mouse will become founder of a transgenic line. Trans genes appear to integrate randomly by illegitimate recombination events. The spatial and temporal control of expression is influenced by cis-acting regulatory elements incorporated in the construct or present at the inte gration site.
An alternative method to introduce new genetic material into mice involves the use of embryonic stem (ES) cells. DNA can be introduced into ES cells in culture, the desired transformants can be selected and placed in recipient blastocysts (see Figure 1 ). The pluripotent ES cells are capable of colonizing all or most of the tissues of the resulting offspring (reviewed by Bradley & Robertso ' n 1986 ). If they participate in the for mation of germ line chimeras, their specific traits can be propagated. Since this methodology allows a great number of cells to be subjected to selective >.steps in culture, it holds a great deal of promise for producing mutations at defi ned loci either by conventional or insertional mutagenesis or by gene replacement via homologous recombination. Initial work focused on a model locus, the gene encoding HPRT or hypoxanthine-guanosine phos phoribosyl transferase. HPRT-deficient mice were produced from ES cells that carried either spontaneous mutations or retroviral inserts in the target gene (Hooper et al 1987; Kuehn et al 1987) . The hprt gene is located on Martin, 1981; Bradley et ai, 1984) . Since large numbers of these cells can be transformed with DNA in culture and subjected to selection, even rare events such as homologous recombination can be detected and the respective cell clone can be isolated. Upon introduction of preselected ES cells into blastocysts and surgical transfer of bias to cysts into a foster mother, chimeric animals can be obtained. Provided the ES cell has maintained its pluripotency, transmission into the germ line is possible. Animals can be bred to generate homozygous mice.
the X chromosome, hence only one mutant copy is needed in male cells to yield a phenotype that can easily be selected. The initial results using the hprt gene as a model established the feasibility of introducing changes in resident chromosomal genes of the mouse. However, most genes of interest are present as diploid copies for which no positive selection procedures exist. We will describe below two different approaches that screen for ES cells that have undergone homologous recombination events in one or another of such nonselectable diploid genes.
PROTO-ONCOGENES AND ONCOGENES
Cellular proto-oncogenes or viral oncogenes are primarily discussed in the context of cancer and not in the context of embryogenesis. However there is a rapidly growing body of information that assigns cellular proto oncogenes a physiologic role in development. The temporal and spatial control of expression, as much as their nature and quantity, determines the outcome of their action. Viral oncogenes or a nonphysiologic dose of cellular proto-oncogenes interfere with development in characteristic ways that can be assessed in the transgenic mouse. Several laboratories have begun to examine the effects of targeting the expression of defined viral oncogenes or their cellular equivalents in preselected tissues or organs, notably the eye lens, the pancreas, and the mammary gland (most recently reviewed by Cory & Adams 1988) . Inasmuch as these studies are focused on oncogenesis, they will not be discussed here. However, this type of experiment can also register the interaction of a specifi c oncogene or proto-oncogene product with unknown factors that defi ne a specifi c cell phenotype in the developing organism. The nature and composition of such factors change during differentiation. Therefore, one may predict that the phenotype of trans genic mice expressing a given oncogene will refl ect not only the nature of the target tissue but also its developmental stage at the time of initial exposure to the oncogene product. One of our laboratories has developed a system to test this prediction.
With the help of the aT trans gene (a promoter sequence of the murine aA-crystallin gene fused to sequences encQding for the tumor antigens of SV 40), we have been able to direct malignant growth to the lens of trans genic mice (Mahon et al 1987) . The lens has a simple architecture. At day El l of gestation, posterior epithelia of the embryonic mouse lens begin to differentiate into crystallin producing fi bers that are destined to form the lens nucleus. T. Nakamura et al (in preparation) have recently compared two very different phenotypes of mouse lines carrying the aT transgene.
Line aTI accumulates SV40 tumor antigens (TAG) in Ell lens epithelia prior to primary fi ber differentiation. Progeny of this line develop fast growing lens tumors comprised of poorly differentiated cells that are largely defi cient in lens crystallin synthesis. By contrast, individuals of line aT2 accumulate TAG at day EI2/13 in differentiating fi ber cells. Their lens tumors grow very slowly and consist of cells that retain some charac teristics of differentiation, including the ability to synthesize signifi cant amounts of crystallins. These observations led us to propose a model that is illustrated in Figure 2 . According to this model, the oncogene products immortalize some basic properties of the initial target cell in which they accumulate. In aTl, the target cells are the embryonic lens epithelia. We postulate that these cells are not yet fully committed to differentiation into fi ber cells and hence, they produce no or very little f3 and y crystallins. Their growth regulation has a higher degree of plasticity, which makes them proliferate fast under the infl uence of the oncogene product. By contrast, the developing lens fi ber cells of aT2 approach terminal differ entiation and produce f3 and y crystallins. These cells proliferate more slowly in the presence of TAG and maintain their program of f3 and y crystallin synthesis. Thus it appears that a powerful transforming activity can be modifi ed by the state of differentiation of the cell.
A quite different approach, designed to assess the role of a proto oncogene in development, has recently been formulated by Mansour et al (1988) , who altered the int-2 gene of ES cells by insertional mutagenesis. Int-2 is a proto-oncogene that displays a highly restricted pattern of expression during mouse organogenesis (Wilkinson et al 1988) , which suggests important functions in mammalian development. Mansour et al developed an elegant method that enabled them to enhance the selection for cells that have undergone homologous recombination at the int-2 10cus. The bacterial neo gene, which confers neomycin resistance, was fused to a promoter active in ES cells. This construct was inserted such that it dis rupted the coding sequence of one of the int-2 exons. In addition, a herpes virus gene encoding thymidine kinase (HSV-TK) was linked to one end of the linear DNA fragment to serve as a negative selectable marker. Upon introduction of this DNA construct by electroporation, a method that insures the integration of a limited number of gene copies (Doetschman et al 1988) , the drug G41S was added to eliminate all cells that did not integrate and express the neo gene. Surviving cells were treated with the nucleoside analog gancyclovir (GANC). This drug was originally devel oped as an antiviral agent because it is cytotoxic for cells containing func tional herpes virus thymidine kinase. In an illegitimate recombination event the entire linear DNA fragment is integrated and HSV-TK is expressed, killing the cell in the presence of GANC. During homologous recom bination, however, the DNA sequence encoding HSV-TK is lost, and the cell survives GANC treatment. The method enhances the selection at least 2000-fold for the rare homologous combination event. It is hoped, of course, that the ES cell containing the int-mutation is able to participate in the formation of germ-line chimeras so that mice expressing the mutant trait can be derived. The example of mice carrying dominant, spontaneous mutations in the c-kit proto-oncogene shows that this approach can lead to interesting developmental phenotypes. Recently c-kit has been identifi ed as the prod uct of the W locus (Geissler et al 1988) . White coat color, sterility, and anemia are characteristic for W locus mutants. These phenotypes have been attributed to failure of stem cell populations to migrate and to proliferate properly. The ability to produce defi ned mutations via homol ogous recombination will allow the role of proto-oncogenes in mammalian development to be probed in a systematic way. For example, the murine homolog of the c-mos proto-oncogene has been linked to meiotic matur ation in frog and mouse oocytes (Mutter et al 1988; Sagata et al 1988; Paules et aI, in preparation). Targeting the chromosomal mos gene in the mouse germ line could reveal similar and additional functions of mos in mammalian development.
HOMEOBOX, PAIRED BOX, AND FINGER STRUCTURE ENCODING GENES
The assumption that structural conservation is indicative of functional conservation prompted many researchers to screen mammalian genomes for the presence of sequences first discovered in developmental control genes of Drosophila (McGinnis et al 1984a,b; Scott & Weiner 1984) . To date three gene families classifi ed by common sequence motifs have been identified in the mouse genome. These include the homeobox (Hox), paired box (Pax), and finger structure (Zp/) encoding genes (reviewed by Dressler & Gruss 1988; Holland & Hogan 1988) .
First indications that these genes may indeed be involved in mammalian developmental control were obtained by studying their temporal and spa tial pattern of expression. The homeobox containing genes are expressed in a tissue and region specifi c manner, the paired box containing gene, Pax 1, is expressed along the entire rostro-caudal axis in segmented structure, and a fi nger containing gene, Mkr2jZpj2, is expressed specifically in neurons (see Holland & Hogan 1988; Dressler & Gruss 1988, for review) .
Investigation of a mouse mutant, undulated (un), strongly supported the view that these conserved genes play a role in development. Un exhibits abnormalities of the vertebral column beginning during embryonic devel opment (Gruneberg 1954) and the adult has distortions along the entire rostro caudal axis. Pax I is expressed in the structures affected by the mutation (Deutsch et a1 1988; Balling et aI1988). Thus, it was rewarding to find that in un mice there is a glycine for serine substitution in the most conserved region of the paired box of Pax 1, which suggests that this mutation is causing the developmental defect (Balling et aI1988). Although the identification of un as a gene controlling mammalian development was made possible by analyzing a preexisting mouse mutant, it is unlikely that mutants for all the members of the above mentioned gene families will be found. Thus alternative approaches, including the generation of dominant gain of function or loss of function mutations, must be explored.
Gain of Function Mutants
A temporally or spatially misdirected expression during embryogenesis may result in phenotypic alterations and consequently help us to defi ne the role of genes involved in developmental control. Using a large genomic fragment including the putative control signals and the coding region of Hox 1.4, Wolgemuth & collaborators (1989) generated several lines of transgenic mice. The rationale was that, by insertion of one or more additional copies of the gene, a fi nely tuned control mechanism could be thrown out of balance in the tissue in which this gene is normally expressed. Indeed, all transgenic animals overexpressed the Hox 1.4 gene in testis as well as in the intestinal tract. In midgestation embryos the level of trans gene transcripts was at least fi vefold higher, particularly in the gut. Interestingly, a phenotype identified as megacolon developed most likely as a conse quence of the activity of the transgene. Mouse mutants exhibiting the megacolon phenotype show a deficiency of myenteric ganglion cells in the colon. These represent neural crest derivatives that migrate into the developing gut (Figure 3) .
In a related type of experiment, Balling et al (1989) used a DNA con struct in which the fJ-actin promoter was placed upstream of the H ox 1.1 coding region in order to express the Hox 1. 1 gene at ectopic sites. Several founder animals were obtained. One of them was used to breed transgenic offspring. The transgenic offspring remained small, did not feed and died soon after birth most likely due to a phenotype known as cleft-palate. These mice show a number of craniofacial abnormalities, including open eyes at birth, non-fused pinnae, and cleft secondary palate. This phenotype resembles the effects observed after application of retinoic acid during pregnancy (retinoic acid embryopathy). Because of the similarity in pheno types, it has been suggested that cranial neural crest cells that participate Annu. Rev. Cell. Biol. 1989.5:181-196 
Loss of Function Mutants
Certain mutant gene products can exert dominant negative effects on development by competing with the wild-type product. Resulting pheno types in which gene function is blocked at the protein level were first described as antimorphs (for review, see Herskowitz 1987) . The possibility to supply mutant gene products via transgene insertion and thereby inter fere with development in the mouse was realized by Stacey et al (1988) .
These authors aimed at generating a mouse model of a human genetic disease, osteogenesis imperfecta type II, which is associated with sub stitutions of single glycine residues in al (1) RNA complementary to messenger RNA has been shown to repress the expression of specific genes in mammalian cells Melton 1985; and in Drosophila embryos where it induces a specific mutant phenotype (Rosenberg et al 1985) . Thus, antisense expression in transgenic mice provides a tool to functionally inactivate a target gene and thereby possibly induce a mutant phenotype.
This approach has been used by Katsuki et al (1988) The fa ct that the trans gene interrupting the dt locus contains a laeZ transcriptional cassette was utilized to obtain stained preparations of the neural tube, which showed f)-galactosidase activity beginning at day E9.5
in the rostral-most region, and involving the entire length of the neural tube by day E13.5. Thus it is likely that the transgene has come under the control of cis-acting regulatory sequences of the dt locus (Kothary et al 1988) . With the help of the inserted laeZ sequence, it should therefore be possible to characterize the dt gene at the molecular level.
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Following work in other systems, Allen et al (1988) have utilized the excellent properties of lacZ as an in situ tracer of gene activity in their design of a general method aimed at detecting genes that are involved in mammalian organogenesis and pattern formation. They microinjected into mouse embryos a lacZ transcription cassette that lacks active cis-acting elements conferring strong spatial or temporal control of expression. If this cassette happens to integrate at a site controlled by a strong promoter that is active in specifi c cell systems of the developing organism, lacZ will also be expressed in these cells from the allele in which it integrated. Indeed, sections obtained from transgenic embryos revealed unique patterns of f3-galactosidase staining that were symmetrically arranged, and affected organs and tissues that differed from one integration event to the other.
The result is best explained by postulating that the transgene integrated into one of a number of chromosomal regions actively expressed during development. The lacZ reporter gene thus came under the control of hitherto unknown genes involved in the regulation of pattern formation.
Such genes can now be traced with the help of the integrated lacZ sequence. Figure 5 Expression of a Hox 1.1 promoter-lacZ fusion gene in a transgenic day EI1.5 embryo. Transgenic mice were generated using a Hox 1.1 promoter-lacZ fusion gene. Day EI1.5 embryos were fi xed in I % formaldehyde, 0.2% glutaraldehyde, 0.02% NP40, I x PBS, washed twice in PBS and stained in I mg/ml X-Gal, 5 mM K3Fe(CN)6' 5 mM K.Fe (CN)6, 2 mM MgCI2, I x PBS. Expression of the transgene is detectable in spinal ganglia, neural tube, mesoderm, and epidermis. Annu. Rev. Cell. Biol. 1989.5:181-196 . Downloaded from www.annualreviews.org Access provided by WIB6417 -Max-Planck-Gesellschaft on 02/23/17. For personal use only.
One of our laboratories has used the p-galactosidase enzymatic activity as a reporter in order to map the tissue-specific control elements of a Hox 1.1 homeobox containing gene. In these experiments the coding region of Hox 1.1 was replaced by the coding region of laeZ, which placed it under the transcriptional and post-transcriptional regulation of Hox 1.1 control elements ( Figure 5 ). This construct was introduced into zygotes and trans genic mouse lines were established and bred. Analysis of the resulting embryos by using the conventional X-gal stain, revealed the presence of p-galactosidase activity. As shown in Figure 5 , a distinct spatial expression pattern was obtained in the central nervous system, as well as in scler otomes and the mesodermal component of several organs (A. Piischel & P. Gruss, in preparation). The overall temporal and spatial expression pattern was similar if not identical to the expression of the endogenous Box 1.1 gene as studied by in situ analysis (Mahon et aI 1988) . If a trans gene integrates into a chromosomal locus subject to genomic imprinting, it can be used as a molecular marker to examine the molecular details of this phenomenon. Since in appropriate crosses the transgene is inherited either from the mother or from the father, it is subject to imprint ing during maternal or paternal gametogenesis. It was demonstrated that methylation of a given trans gene is accurately switched between the maternal and the paternal pattern (Reik et a1 1987; Sapienza et al 1987) .
TRANSGENES AND GENOMIC IMPRINTING
Moreover, expression studies using the transgene RSV-mye as a probe revealed that the expression is strictly dictated by its paternal origin (Swain et aI1987) . Only the transgenic alleles inherited from the male parent were expressed, while the same transgene inherited from the female parent was not. Interestingly, the transgene inherited from the father was underAnnu. Rev. Cell. Biol. 1989.5:181-196 . Downloaded from www.annualreviews.org methylated. Thus there is a correlation between the degree of methylation and the activity or inactivity of a gene. These elegant experiments clearly document differential imprinting imposed on the genetic material during gametogenesis, and the molecular details involved are under investigation.
CONCLUSIONS
Our review points out various approaches toward defi ning genes that regulate mammalian genes and ways to modify their action in the trans genic mouse. In addition, we discuss experiments that probe the inter relationship between development and oncogenesis. 
